Measured one way, success for peripheral vascular intervention (PVI) in the femoropopliteal arteries for patients with intermittent claudication has improved, as the need for repeat PVI appears to be ...

A self-expanding nitinol stent is associated with high patency and durability in patients with atherosclerotic popliteal artery disease, according to a study published in the January 2013 issue of ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

The popliteal artery branches off from the femoral artery. It is located in the knee and the back of the leg. Its courses near the adductor canal and the adductor hiatus, distinctive open areas inside ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...

PAD patients with claudication undergoing peripheral vascular interventions (PVIs) in contemporary practice have a 4% risk of amputation within 4 years, with higher risk seen among those ...

BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — In a session focused on lower-extremity intervention in superficial femoral artery and popliteal ...

Although atherosclerosis is a generalized metabolic disorder, the plaque tends to build up at bifurcations of major vessels, including in the lower extremities. Here, the superficial femoral artery ...

The FDA approved W.L. Gore’s third-generation, self-expanding stent for the treatment of peripheral artery disease. CE-marked in 2011, the device is designed to work better with natural knee movement ...